MARKET

CDXS

CDXS

Codexis Inc
NASDAQ
2.640
+0.180
+7.32%
After Hours: 2.510 -0.13 -4.92% 19:27 05/12 EDT
OPEN
2.610
PREV CLOSE
2.460
HIGH
2.700
LOW
2.570
VOLUME
450.13K
TURNOVER
--
52 WEEK HIGH
6.08
52 WEEK LOW
1.900
MARKET CAP
218.71M
P/E (TTM)
-2.9690
1D
5D
1M
3M
1Y
5Y
1D
Codexis (CDXS) Receives a Buy from Craig-Hallum
TipRanks · 11h ago
Weekly Report: what happened at CDXS last week (0505-0509)?
Weekly Report · 15h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Codexis (CDXS) and Ironwood Pharma (IRWD)
TipRanks · 5d ago
Weekly Report: what happened at CDXS last week (0428-0502)?
Weekly Report · 05/05 09:18
Recent uptick might appease Codexis, Inc. (NASDAQ:CDXS) institutional owners after losing 36% over the past year
Simply Wall St · 05/03 14:18
Opaleye Management Makes a Bold Move with Codexis Stock Acquisition
TipRanks · 05/03 02:07
Opaleye Management Makes Strategic Move with Codexis Stock Purchase
TipRanks · 04/30 02:08
Weekly Report: what happened at CDXS last week (0421-0425)?
Weekly Report · 04/28 09:19
More
About CDXS
More
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Recently
Symbol
Price
%Change

Webull offers Codexis Inc stock information, including NASDAQ: CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.